High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.
Adam J. Nelson(Clinical Research Institute), Christopher B. Granger(Clinical Research Institute), Sara B. Calvert(Clinical Research Institute), Kerrin Gallagher(Wilmington University), Michael G. Nanna(Yale University), Mark J. Cziraky(Wilmington University), Neha J. Pagidipati(Duke University), Kevin Haynes(University of Pennsylvania), Zubin J. Eapen, Sonali Shambhu(Wilmington University)
Cited by 146
Related Papers
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
|New England Journal of Medicine|2019|1.9k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
|New England Journal of Medicine|2013|1.5k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|809